Explore 3 Stock Ideas & Industry Insights Download Free Report

18889881171
Shopping Cart 0
countryflagUS
Login

Advanced Biomedical Technologies Inc

Healthcare US ABMT

0.0005USD
0.00(0%)

Last update at 2026-06-19T20:00:00Z

Day Range

0.00020.0002
LowHigh

52 Week Range

0.00010.0005
LowHigh

Fundamentals

  • Previous Close 0.0005
  • Market Cap0.04M
  • Volume29714
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-0.40887M
  • Revenue TTM0.11M
  • Revenue Per Share TTM0.002
  • Gross Profit TTM 0.08M
  • Diluted EPS TTM-

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-10-31 2021-10-31 2020-10-31 2019-10-31 2018-10-31
Type yearly yearly yearly yearly yearly
Date 2022-10-31 2021-10-31 2020-10-31 2019-10-31 2018-10-31
Income before tax -0.51548M -0.72944M -0.67200M -0.94882M -0.95332M
Minority interest - - 0.00000M 0.00000M 0.00000M
Net income -0.51548M -0.72944M -0.97866M -1.25753M -0.95332M
Selling general administrative - - 0.28M 0.32M 0.56M
Selling and marketing expenses - - - - -
Gross profit 0.22M 0.09M 0.07M 0.00406M 0.00000M
Reconciled depreciation - - 0.06M 0.02M 0.02M
Ebit -0.18491M -0.40872M -0.32082M -0.60474M -0.65275M
Ebitda -0.16601M -0.36744M -0.28269M -0.60126M -0.63645M
Depreciation and amortization 0.02M 0.04M 0.04M 0.00348M 0.02M
Non operating income net other - - - - 0.00000M
Operating income -0.17988M -0.39486M -0.32082M -0.60474M -0.63402M
Other operating expenses 0.45M 0.57M 0.44M 0.62M 0.63M
Interest expense 0.33M 0.32M 0.33M 0.33M 0.30M
Tax provision - - 0.00000M 0.00000M 0.00000M
Interest income - - 0.00004M 0.00002M 0.00004M
Net interest income - - -0.32890M -0.32639M -0.30053M
Extraordinary items - - - - 0.00000M
Non recurring - - - - 0.00000M
Other items - - - - 0.00000M
Income tax expense -0.00000M -0.00000M 0.31M 0.31M -0.01873M
Total revenue 0.27M 0.17M 0.12M 0.01M 0.00000M
Total operating expenses 0.40M 0.49M 0.39M 0.61M 0.63M
Cost of revenue 0.05M 0.08M 0.05M 0.00760M 0.00000M
Total other income expense net -0.33560M -0.33458M -0.35118M -0.34408M -0.01877M
Discontinued operations - - - - 0.00000M
Net income from continuing ops - - -0.67200M -0.94882M -0.95332M
Net income applicable to common shares - - -0.67200M -0.94882M -0.95332M
Preferred stock and other adjustments - - - - 0.00000M
Breakdown 2022-10-31 2021-10-31 2020-10-31 2019-10-31 2018-10-31
Type yearly yearly yearly yearly yearly
Date 2022-10-31 2021-10-31 2020-10-31 2019-10-31 2018-10-31
Total assets 0.40M 0.45M 0.47M 0.22M 0.14M
Intangible assets - - - - 0.00000M
Earning assets - - - - -
Other current assets 0.04M 0.08M 0.03M 0.05M 0.03M
Total liab 8.33M 8.83M 7.87M 6.70M 5.76M
Total stockholder equity -7.93643M -8.38417M -7.40180M -6.47824M -5.61901M
Deferred long term liab - - - - 0.00000M
Other current liab 0.69M 0.70M 6.49M 1.64M 1.44M
Common stock 0.00071M 0.00071M 0.00070M 0.00070M 0.00070M
Capital stock - - 0.00070M 0.00070M 0.00070M
Retained earnings -11.50129M -10.98580M -10.25636M -9.58144M -8.63262M
Other liab - - - - 0.00000M
Good will - - - - 0.00000M
Other assets - - - - 0.00000M
Cash 0.00485M 0.04M 0.20M 0.00559M 0.00686M
Cash and equivalents - - - - -
Total current liabilities 8.33M 8.83M 7.86M 6.70M 5.76M
Current deferred revenue 0.83M 1.24M 1.34M 0.14M -
Net debt 6.81M 6.85M -0.16661M 4.91M 4.32M
Short term debt 6.81M 6.89M 0.03M 4.92M 4.33M
Short long term debt - - 4.71M 4.92M 4.33M
Short long term debt total 6.81M 6.89M 0.04M 4.92M 4.33M
Other stockholder equity 2.90M 2.87M 2.83M 2.77M 2.74M
Property plant equipment - - 0.14M 0.10M 0.10M
Total current assets 0.29M 0.30M 0.33M 0.12M 0.04M
Long term investments - - - - 0.00000M
Net tangible assets - - -7.40180M -6.47824M -5.61901M
Short term investments - - - - 0.00000M
Net receivables - - 0.03M 0.05M 0.03M
Long term debt - - - - 0.00000M
Inventory 0.25M 0.19M 0.10M 0.06M -0.03265M
Accounts payable 0.00028M 0.00242M 0.00023M 0.00249M 0.00000M
Total permanent equity - - - - 0.00000M
Noncontrolling interest in consolidated entity - - - - 0.00000M
Temporary equity redeemable noncontrolling interests - - - - 0.00000M
Accumulated other comprehensive income 0.66M -0.27011M 0.02M 0.33M 0.27M
Additional paid in capital - - - - 0.00000M
Common stock total equity - - - - 0.00000M
Preferred stock total equity - - - - 0.00000M
Retained earnings total equity - - - - 0.00000M
Treasury stock - - - - 0.00000M
Accumulated amortization - - - - 0.00000M
Non currrent assets other - - - -0.00000M -0.00001M
Deferred long term asset charges - - - - 0.00000M
Non current assets total 0.10M 0.15M 0.14M 0.10M 0.10M
Capital lease obligations - - 0.04M - 0.00000M
Long term debt total - - - - 0.00000M
Breakdown 2022-10-31 2021-10-31 2020-10-31 2019-10-31 2018-10-31
Type yearly yearly yearly yearly yearly
Date 2022-10-31 2021-10-31 2020-10-31 2019-10-31 2018-10-31
Investments - - -0.03071M -0.01857M -0.06441M
Change to liabilities - - 1.19M 0.24M 0.05M
Total cashflows from investing activities - -0.05153M -0.03071M -0.01857M -0.06441M
Net borrowings - - -0.42378M 0.76M 0.90M
Total cash from financing activities 0.70M 0.73M -0.42782M 0.76M 0.90M
Change to operating activities - - 0.00843M 0.00040M 0.00040M
Net income -0.51548M -0.72944M -0.67200M -0.94882M -0.95332M
Change in cash -0.03213M -0.16469M 0.20M -0.00127M -0.00060M
Begin period cash flow 0.04M 0.20M 0.00559M 0.00686M 0.00746M
End period cash flow 0.00485M 0.04M 0.20M 0.00559M 0.00686M
Total cash from operating activities -0.73453M -0.84561M 0.65M -0.74253M -0.83242M
Issuance of capital stock - - - - -
Depreciation 0.02M 0.04M 0.06M 0.02M 0.02M
Other cashflows from investing activities - - - - 0.00000M
Dividends paid - - 0.00000M - 0.00000M
Change to inventory -0.09105M -0.08329M -0.03128M -0.06547M -0.06547M
Change to account receivables 0.03M -0.04732M 0.02M -0.01775M -0.01686M
Sale purchase of stock - - - - 0.00000M
Other cashflows from financing activities -0.00726M -0.03024M -0.38369M 0.76M 0.90M
Change to netincome - - 0.07M 0.03M 0.07M
Capital expenditures 0.00000M 0.05M 0.03M 0.02M 0.06M
Change receivables - - - - 0.00000M
Cash flows other operating - - - - 0.00000M
Exchange rate changes - - - - 0.00000M
Cash and cash equivalents changes - - - - 0.00000M
Change in working capital -0.26654M -0.20128M 1.19M 0.16M 0.04M
Stock based compensation - - - - -
Other non cash items 0.03M 0.04M 0.07M 0.03M 0.07M
Free cash flow -0.73453M -0.89714M 0.62M -0.76109M -0.89683M

Peer Comparison

Sector: Healthcare Industry: Medical Devices

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
ABMT
Advanced Biomedical Technologies Inc		 - -% 0.0005 - - 0.32 - 25.61 -9.8581
ABT
Abbott Laboratories		 -0.58 0.66% 87.83 25.97 17.24 3.57 3.20 3.81 16.75
SYK
Stryker Corporation		 -3.11 1.01% 304.69 44.07 24.94 5.51 6.12 6.05 25.73
MDT
Medtronic PLC		 -0.07 0.09% 79.27 26.60 15.87 3.35 2.08 3.90 14.12
BSX
Boston Scientific Corp		 -0.96 2.12% 44.33 31.49 17.24 4.41 3.65 4.88 19.19

Reports Covered

Stock Research & News

View All

Profile

Advanced Biomedical Technologies, Inc., a development stage company, designs, develops, manufactures, and markets biomaterial internal fixation devices. It offers polymer osteosynthesis devices, such as surgical screws, binding wires, rods, and related medical devices for the treatment of orthopedic trauma, sports-related medical treatment, cartilage repair, and related treatments, as well as for reconstructive dental procedures. The company was formerly known as Geostar Mineral Corporation and changed its name to Advanced Biomedical Technologies, Inc. in March 2009. Advanced Biomedical Technologies, Inc. was founded in 2002 and is based in New York, New York.

Advanced Biomedical Technologies Inc

200 Park Avenue, New York, NY, United States, 10166

Key Executives

Name Title Year Born
Ms. Hui Wang CEO, Controller & Director 1970
Mr. Chi Ming Yu Pres, Treasurer, Compliance Officer & Director 1974
Mr. Kai Gui Sec., CFO, COO & Director 1970
Prof. Puyi Sheng M.D., Ph.D. Chief Medical Officer 1967
Prof. Shangli Liu M.D., Ph.D. Chairman of Scientific Board & Chief Medical Advisor of Greater China NA
Dr. John Thomas Lynch Jr. Chief Officer of Dental Technologies NA
Mr. Chi Ming Yu President, Treasurer, Compliance Officer & Director 1974
Mr. Kai Gui Secretary, CFO, COO & Director 1970
Prof. Puyi Sheng M.D., Ph.D. Chief Medical Officer 1968

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.